Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Mayer MC, Berg JL, Perfler B, Hatzl S, Herzog SA, Bachmaier G, Berghold A, Reinisch A, Wölfler A, Sill H, Zebisch A. miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms. Ann Hematol 2021;100:2845-2847. [PMID: 34291333 DOI: 10.1007/s00277-021-04598-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2021] [Accepted: 07/06/2021] [Indexed: 02/07/2023]

For:	Mayer MC, Berg JL, Perfler B, Hatzl S, Herzog SA, Bachmaier G, Berghold A, Reinisch A, Wölfler A, Sill H, Zebisch A. miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms. Ann Hematol 2021;100:2845-2847. [PMID: 34291333 DOI: 10.1007/s00277-021-04598-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2021] [Accepted: 07/06/2021] [Indexed: 02/07/2023]

Number

Cited by Other Article(s)

Zebisch A, Sill H. How do non-coding RNAs impact treatment regimens currently being used in AML? Expert Rev Anticancer Ther 2022;22:331-333. [PMID: 35245428 DOI: 10.1080/14737140.2022.2049764] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]